Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients  by Allen, Alice C. et al.
Kidney International, Vol. 60 (2001), pp. 969–973
Mesangial IgA1 in IgA nephropathy exhibits aberrant
O-glycosylation: Observations in three patients
ALICE C. ALLEN, ELAINE M. BAILEY, PAUL E.C. BRENCHLEY, KATHARINE S. BUCK,
JONATHAN BARRATT, and JOHN FEEHALLY
Department of Nephrology, Leicester General Hospital, Leicester, and Manchester Institute of Nephrology and Transplantation,
Manchester Royal Infirmary, Manchester, England, United Kingdom
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glyco- usually extended with galactose to form the disaccharide
sylation: Observations in three patients. Gal1,3GalNAc, which may in turn be further extended
Background. In IgA nephropathy (IgAN), circulating IgA1 with one or two sialic acid units [4]. Thus, each O-glycanmolecules display an abnormal pattern of O-glycosylation. This
may have one of four structures. Each IgA1 heavy chainabnormality may potentially contribute to mesangial IgA1 depo-
sition, but this is unproven because the O-glycosylation of mes- has multiple potential O-glycosylation sites, and occu-
angial IgA1 has not been analyzed. pancy of these sites is variable. Therefore, an array of
Methods. IgA1 was eluted from glomeruli isolated from the IgA1 “O-glycoforms” is possible. It is likely that serumkidneys of three IgAN patients obtained after nephrectomy or
contains of a mixture of IgA1 O-glycoforms, with varyingat postmortem. Serum from these patients, other patients with
IgAN, and controls was subjected to the same treatment as degrees of galactosylation and sialylation.
the glomerular eluates. The O-glycosylation of eluted and se- We and others have shown that in IgAN, the O-glyco-
rum IgA1 was measured by lectin binding using an enzyme- sylation pattern of serum IgA1 is abnormal [1, 5–9]. Thislinked immunosorbent assay-based system.
was initially demonstrated by the altered binding of lec-Results. In all three cases, the lectin binding of IgA1 eluted
tins with specificity for oligosaccharides typically presentfrom the glomeruli of IgAN patients was markedly higher than
that of the serum IgA1 of the same individual, and also all but within O-linked glycans to serum IgA1 [1, 5–7], the most
one of a series of serum IgA1 samples from other patients and consistent finding being the increased binding of lectins
controls.
with an affinity for ungalactosylated terminal GalNAcConclusions. The higher lectin binding of glomerular com-
[5, 6]. This abnormality of lectin binding is probably duepared with serum IgA1 suggests that O-glycosylated IgA1 mol-
ecules abnormally and selectively deposit in the kidney. These to the reduced occurrence of galactosylated and sialylated
results provide the first evidence that mesangial IgA1 is abnor- chains, leading to increased frequency of O-glycans con-
mally O-glycosylated, and support a direct role for abnormal
sisting of single GalNAc units alone. This abnormalIgA1 O-glycosylation in the mechanism of mesangial IgA depo-
O-glycosylation of serum IgA1 has now been confirmedsition in IgAN.
directly by more precise analytical methods [7–9].
There has been considerable speculation about the pos-
sible pathogenic consequences of this serum IgA1 abnor-The mechanism of mesangial deposition of IgA1 in
IgA nephropathy (IgAN) is unknown, but a role has been mality [1, 2], but the contribution of aberrant O-glycosyl-
suggested for altered O-glycosylation of IgA1 [1, 2]. ation to the mechanism of mesangial IgA1 deposition in
Human IgA1 is unusual among serum proteins in its human IgAN has yet to be fully elucidated. To date,
possession of a series of closely located O-glycans in the no study has addressed the O-glycosylation pattern of
hinge region of the molecule [3.] These O-glycans are mesangial IgA1. Elution from renal biopsy specimens
short chains, each based on a core N-acetyl galactosamine can yield nanogram quantities of IgA1 [10], but available
(GalNAc) unit linked to the amino acid backbone and methods of carbohydrate analysis require more than this
to obtain reliable results.
In this study, we had the unique opportunity to analyzeKey words: glomerulonephritis, Vicia villosa lectin, Helix aspersa lectin,
lectin binding, sialylation. the O-glycosylation of IgA1 eluted from nephrectomy
or postmortem kidneys of three patients with IgAN. In
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Accepted for publication March 28, 2001 was highly abnormal in comparison to the serum IgA1 of
the same patient, other patients with IgAN, and controls. 2001 by the International Society of Nephrology
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METHODS scopic hematuria and transplant nephrectomy was re-
quired. Histology showed extensive glomerulosclerosisSubjects
with interstitial fibrosis and hemorrhage. Mesangial IgA
Serum was obtained with informed consent from 20
deposits persisted. One half of the kidney was available
patients with biopsy-proven IgAN (14 male, mean age
for this study.
43.7, range 32 to 63 years) and 16 healthy control subjects
(9 male, mean age 40.3, range 21 to 70 years) with no Preparation of glomeruli from nephrectomy specimens
evidence of renal or systemic disease. In each case, the outer cortex was dissected from per-
Renal cortex was obtained at nephrectomy or autopsy fused kidney tissue, minced, and washed to remove all
from three patients, A, B and C, all with biopsy-proven traces of blood, and glomeruli were isolated by conven-
IgAN. tional sieving techniques. Briefly, the tissue was forced
through a series of sieves of decreasing mesh size (500,Patient A
250, and 75m), washing through with buffer. Glomeruli
A 64-year-old man presented in 1991 with proteinuria from the top of the 75 m mesh were washed thoroughly
(1.5 g/24 h), microscopic hematuria, hypertension with and examined by microscopy to check for purity. The
preserved renal function, and serum creatinine 116 mol/L glomeruli were stored at 80C in a buffer containing
(1.3 mg/dL). Renal biopsy showed characteristic features 0.5 UL1 aprotinin as the protease inhibitor prior to the
of IgAN: diffuse mesangial hypercellularity with mesan- elution of IgA1.
gial IgA and C3 deposits. One year later, he had an episode
of macroscopic hematuria, and a solid mass lesion was Elution of IgA1 from glomeruli
identified in the upper pole of the left kidney on com- Experiments A and C. The glomeruli were thawed
puted tomography scanning. He underwent left nephrec- and washed four times in phosphate-buffered saline
tomy: The mass proved to be a renal cell carcinoma, and (PBS), with repeated passes through a 21-gauge needle
the features of IgA in the remainder of the kidney were to disrupt the glomerular structure. The wash superna-
unchanged from the previous biopsy. The tumor-free tants were pooled and dialyzed against water, and these
lower pole of the kidney was obtained for this study. eluates were concentrated by centrifugal evaporation at
ambient temperature.Patient B
Experiment B. Kidney B was obtained during a study
A 41-year-old man presented in 1978 with loin pain in investigating the antigen specificity of mesangially depos-
association with hematuria and proteinuria (1.3 g/24 h). ited antibodies, and the elution protocol was designed to
A renal biopsy was performed in 1982 and showed char- dissociate the eluted IgA from other possible complexed
acteristic features of progressive IgAN: Glomeruli showed proteins. The glomeruli were eluted in 0.1 mol/L citrate
changes ranging from normal to diffuse globular or seg- buffer at pH 3.0 for 20 minutes at 4C. The eluate was
mental mesangial sclerosis with diffuse granular deposits neutralized to pH 7.5 with Tris and concentrated by
of mesangial IgA and C3. In 1989, the patient (aged 55) positive pressure ultracentrifugation.
was admitted to Manchester Royal Infirmary and died To ensure that these protocols were effective and were
of cardiorespiratory failure. At postmortem, kidney tis- not selective with respect to the IgA1 glycoforms eluted,
sue was obtained for glomerular elution studies. glomerular tissue from kidney A was first subjected to
PBS elution and then to a second citrate elution as de-
Patient C scribed for kidney B. The concentration and O-glycosyla-
A 48-year-old man developed end-stage renal disease tion of the IgA1 contained in the two kidney-A eluates
caused by IgAN in 1991. He received a cadaveric renal was compared by enzyme-linked immunosorbent assay
transplant in 1992, which failed in 1996 because of (ELISA) and lectin binding assay as described later in
chronic rejection, although there was immunohistologi- this article. Finally, after further washing with PBS, the
cal evidence of recurrent mesangial IgA deposition at postelution glomerular tissue was stained with peroxi-
the time of graft failure. He received a second cadaveric dase-conjugated anti-IgA and examined microscopically
transplant in 1996. Function was satisfactory for 18 to check for residual IgA.
months, but then there was a relentless decline into renal
Preparation of serum IgAfailure with nephrotic range proteinuria and no evidence
of rejection. Biopsy showed recurrent IgAN: mesangial The lectin binding of eluted glomerular IgA1 from
IgA with diffuse glomerular hypercellularity and pro- each experiment was compared with that of serum IgA1
gressive glomerulosclerosis. The graft failed in 1999. He from the nephrectomized subject and from other individ-
returned to maintenance dialysis, and immunosuppres- uals. In each case, the serum samples were subjected to
sion was gradually withdrawn. One month later, the graft the same “elution” treatment and stored under the same
conditions as the glomerular eluate.became increasingly swollen and tender with macro-
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Experiments A and C. Duplicate aliquots of serum as absorbance at 492 nm. For each sample, the lectin
binding results were expressed per unit IgA1 (A492 lectin/from patients A and C, 25 other IgAN patients and 21
controls were diluted in an equal volume of PBS/aproti- A492 IgA1). We have found that these lectin binding
assays give constant values for lectin binding/IgA1 whennin buffer and stored at 80C.
Experiment B. Serum IgA from patient B, five other samples are used at IgA1 concentrations above 0.1 g/mL
(data not shown). Dose response curves of anti-IgA1IgAN patients and six controls was exposed to 0.1 mol/L
citrate elution buffer for 30 minutes at 4C and then and lectins binding to both serum and to the glomerular
eluate in these assays were parallel and reached satura-restored to PBS immediately prior to the lectin binding
assays. tion and background binding at the same dilution points.
This indicated that the lectin binding is to IgA1 rather
Dissociation of possible IgA1 complexes than the unlikely possibility of any other proteins non-
specifically bound to the anti-IgA–coated wells.The elution protocol used for kidney B (0.1 mol/L
sodium citrate, pH 3) was designed to dissociate IgA1
Statistical analysisfrom complexes with other proteins. The lectin binding
of this eluate was compared with serum IgA1 treated in The lectin binding of serum IgA1 from patient and
the same manner. We chose to elute kidneys A and C control groups was compared by unpaired t tests.
with PBS and mechanical disruption alone, since this
proved sufficient to eluate the IgA from the glomeruli
RESULTSand was a gentler treatment less likely to affect the IgA1
Between 5 and 20g IgA1 was eluted from the glomer-O-glycans. However, to demonstrate that the lectin bind-
uli of each of the three kidney cortex specimens. Theing of the IgA1 eluted from these glomeruli was indeed
IgA concentration and lectin binding of the first (PBS)to IgA1 and not to other complexed proteins, these elu-
and the second (citrate) eluates from kidney A were com-ates also were treated with sodium citrate and the lectin
pared. The PBS eluate contained 78% of the IgA ob-binding results compared with those of IgA1 eluted with
tained from this kidney, and the eluates obtained by thePBS alone.
two methods did not differ in their lectin binding profiles.Kidney A. After PBS elution, glomeruli from kidney
The postelution kidney tissue was negative for IgA byA were subjected to a second elution with sodium citrate,
immunoperoxidase staining.as described previously for kidney B. The lectin binding
The lectin binding of the glomerular IgA1 samplesof the PBS and citrate eluates were then compared with
was compared with that of serum samples treated in theeach other.
same manner (Fig. 1). In all the experiments, the VVKidney C. The glomerular eluate obtained from kid-
ney C was incubated with 0.1 mol/L sodium citrate, pH 3, and HA lectin binding of serum IgA1 from IgAN was
for 30 minutes at 4C and then restored to PBS immedi- significantly higher than controls. All the glomerular
ately before measuring its lectin binding in parallel with IgA1 samples had higher VV and HA lectin binding than
the same eluate, which had been exposed to PBS only. the serum IgA1 of the same subject treated in the same
fashion. Indeed, the glomerular eluates showed the high-
Lectin binding assays est VV lectin binding of all the samples, and the HA
The O-glycosylation profile of IgA1 samples was mea- lectin binding of the glomerular eluates was higher than
sured by the binding of lectins from Vicia villosa (VV) all but one serum IgA1.
and Helix aspersa (HA), which are specific for terminal For kidneys A and C, which were initially eluted with
GalNAc and have previously been used to demonstrate PBS alone, the lectin binding of eluates after complex
abnormal IgA1 O-glycosylation in IgAN [5, 6, 11]. Briefly, dissociation with 0.1 mol/L sodium citrate, pH 3, was
96-well immunoplates were coated with rabbit anti-human also measured. No change in the lectin binding of these
IgA antibody, washed, and blocked with 2% bovine se- samples was observed after citrate complex dissociation,
rum albumin in PBS. Glomerular eluates and serum sam- indicating that lectin binding was indeed to IgA1 and not
ples, which had been treated in the same manner, were to other proteins that may be complexed to it (Table 1).
diluted to 1 g/mL IgA1 in PBS; 20 L aliquots of each
sample were applied to three sets of duplicate wells to
DISCUSSIONcapture IgA. Biotinylated VV and HA lectins and mono-
Abnormal O-glycosylation of serum IgA1 in IgAN isclonal anti-IgA1 were applied to the wells. Lectin binding
now well established. The available evidence points towas detected with horseradish peroxidase-conjugated av-
a lack of terminal galactosylation and sialylation leadingidin and anti-IgA1 binding with horseradish peroxidase-
to increased frequency of truncated O-glycan chains con-conjugated anti-mouse immunoglobulin antibody. The re-
sisting of GalNAc alone [5–9].action was developed with OPD/H2O2 substrate and
stopped with 1 mol/L H2SO4, and the results were read There are plausible reasons why this O-glycosylation
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Fig. 1. Binding of Vicia villosa (VV) and Helix aspersa (HA) lectins to serum and mesangial IgA1. Binding of VV (A) and HA (B) lectins to
serum IgA1 from IgAN and controls (); serum IgA1 from patients A, B, and C (); and IgA1 eluted from the glomeruli of patients A, B, and
C (). In all of the experiments, both the VV and HA lectin binding of serum IgA1 from patients with IgAN was significantly higher than that
of controls (as indicated by the P values on each graph), and the lectin binding to mesangial IgA1 was higher than to serum IgA1 of the same
subject. Note the ratios of A492lectin:A492IgA1 were derived from raw data and are arbitrary values that vary between assay runs. Therefore, the
ordinate scales differ between the experiments and direct comparisons between the different experiments should not be made.
abnormality may be directly pathogenic in IgAN [1, 2].
Altered O-glycosylation might favor self-aggregation of
IgA1 [12] or act as an autoantigen in immune complexesTable 1. Effect of complex dissociation on lectin binding of IgA1
with IgG [13]. Macromolecular IgA1 complexes formedeluted from glomeruli
by either of these mechanisms might be particularly prone
VV binding HA binding
to mesangial trapping. There is also evidence for increased(A492VV/A492IgA1) (A492HA/A492IgA1)
binding of abnormally O-glycosylated IgA1 to extracel-PBS Citrate PBS Citrate
lular matrix components [14, 15], again promoting mes-Eluate A 1.23 1.19 0.89 0.74
angial deposition. Furthermore, abnormally O-glycosy-Eluate B — 0.41 — 0.53
Eluate C 0.35 0.34 0.54 0.55 lated IgA1 from human IgAN patients has been shown
Eluates from kidneys A and C were eluted by washing glomeruli in PBS with to accumulate preferentially in the glomeruli of perfused
mechanical disruption. To ensure that lectins were binding to IgA1 rather than
rat kidneys [16], but the pattern of deposition in thisother proteins complexed to it in the subsequent lectin binding assays, any
complexes were dissociated by incubation in 0.1 mol/L sodium citrate, pH 3 for model is somewhat different to that seen in human IgAN,
30 minutes at 4C and the lectin binding of this dissociated IgA1 compared to
and the cross-species nature of the experiment makes itthat exposed to PBS only. Lectin binding of eluted IgA1 was not altered by
citrate treatment, and remained higher than that of serum IgA1. Kidney B was difficult to interpret its true significance.
eluted directly with sodium citrate, and no values are available for PBS-eluted
IgA1. Currently, there is no direct evidence that aberrant
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(Grant G84/4611). Part of this work was presented in abstract formO-glycosylation really is involved in the mechanism of
at the 32nd American Society of Nephrology Annual Meeting, 1999
mesangial IgA1 deposition in human IgAN. Hitherto, it (Miami Beach, FL, USA).
has not been known whether the IgA1 molecules depos-
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